cysteine has been researched along with Broad Beta Disease in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 6 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Innerarity, TL; Mahley, RW; Weisgraber, KH | 1 |
Dobmeyer, J; Feussner, G; Lohrmann, J | 1 |
Albanese, M; Feussner, G; Mann, WA; Schuster, H; Valencia, A | 1 |
Chen, M; Feussner, G; Fisher, E; Hoffmann, MM; März, W; Nauck, M; Scharnagl, H; Wieland, H | 1 |
Brewer, HB; Lohse, P; Rader, DJ | 1 |
Fazio, S; Horie, Y; Rall, SC; Weisgraber, KH; Westerlund, JR | 1 |
Brennan, SO; George, PM; Janus, ED; Nye, ER; Rall, SC; Wardell, MR; Weisgraber, KH | 1 |
de Knijff, P; Havekes, L; Klasen, E; Utermann, G | 1 |
de Knijff, P; Frants, RR; Havekes, LM; Klasen, EC; Smit, M | 1 |
9 other study(ies) available for cysteine and Broad Beta Disease
Article | Year |
---|---|
Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.
Topics: Apolipoproteins; Apolipoproteins E; Arginine; Cysteamine; Cysteine; Homozygote; Humans; Hyperlipoproteinemia Type III; Kinetics; Lipoproteins, LDL; Receptors, Cell Surface; Receptors, LDL | 1982 |
Rapid and reliable identification of human apolipoprotein E1 (Gly127-->Asp, Arg158-->Cys) variant.
Topics: Apolipoproteins E; Arginine; Aspartic Acid; Cysteine; Glycine; Humans; Hyperlipoproteinemia Type III; Isoelectric Focusing; Mutation; Polymerase Chain Reaction | 1995 |
Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
Topics: Adolescent; Adult; Age of Onset; Aged; Amino Acid Sequence; Apolipoprotein E2; Apolipoproteins E; Arginine; Base Sequence; Cysteine; Female; Genetic Variation; Heparin; Humans; Hyperlipoproteinemia Type III; Isoelectric Focusing; Lipoproteins; Male; Middle Aged; Molecular Sequence Data; Pedigree; Protein Structure, Secondary; Sequence Analysis, DNA | 1996 |
Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.
Topics: Adult; Amino Acid Sequence; Apolipoprotein E2; Apolipoproteins E; Arginine; Base Sequence; Cells, Cultured; Cysteine; Female; Fibroblasts; Heterozygote; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Lipoproteins, VLDL; Male; Middle Aged; Mutation; Polymorphism, Restriction Fragment Length; Receptors, LDL | 1998 |
Heterozygosity for apolipoprotein E-4Philadelphia(Glu13----Lys, Arg145----Cys) is associated with incomplete dominance of type III hyperlipoproteinemia.
Topics: Adolescent; Adult; Aged; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Arginine; Child; Cysteine; DNA; Electrophoresis, Polyacrylamide Gel; Female; Genes, Dominant; Glutamates; Glutamic Acid; Heterozygote; Homozygote; Humans; Hyperlipoproteinemia Type III; Lysine; Male; Middle Aged; Pedigree; Phenotype; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length | 1992 |
The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia.
Topics: Amino Acid Sequence; Apolipoproteins E; Binding Sites; Binding, Competitive; Cloning, Molecular; Cysteine; Escherichia coli; Genetic Variation; Genetic Vectors; Heparin; Homozygote; Humans; Hyperlipoproteinemia Type III; Kinetics; Receptors, LDL; Recombinant Proteins | 1992 |
Apolipoprotein E2-Dunedin (228 Arg replaced by Cys): an apolipoprotein E2 variant with normal receptor-binding activity.
Topics: Amino Acid Sequence; Apolipoprotein E2; Apolipoproteins E; Arginine; Cysteine; Diseases in Twins; Electrophoresis, Gel, Two-Dimensional; Genetic Variation; Heterozygote; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type V; Lipoproteins; Male; Middle Aged; Peptide Mapping; Protein Conformation; Receptors, LDL | 1990 |
Characterisation and mode of inheritance of apolipoprotein E3-Leiden.
Topics: Apolipoprotein E3; Apolipoproteins E; Cysteine; Genes, Dominant; Hyperlipoproteinemia Type III; Isoelectric Focusing; Male; Netherlands; Pedigree; Protein Binding; Receptors, LDL | 1987 |
Familial dysbetalipoproteinemic subjects with the E3/E2 phenotype exhibit an E2 isoform with only one cysteine residue.
Topics: Apolipoproteins E; Cysteine; Genetic Variation; Heterozygote; Humans; Hyperlipoproteinemia Type III; Isoelectric Focusing; Phenotype | 1987 |